Announced
Completed
Financials
Tags
Biotechnology
Friendly
Acquisition
Venture Capital
Private Equity
Domestic
nanotechnology
Completed
Private
United States
Minority
Synopsis
A consortium of investors including Hanwha Corporate Venture Capital, OIC, Catalus Capital and Ascent Funds completed a $50m investment in Forge Nano, a biotechnology company. “This funding milestone allows us to fulfill the customer demand that already exists for our advanced batteries and equipment. As we move to grow our Atomic Armor technology in the Lithium-ion market, we are excited to finally be able to internally provide a finished battery solution at scale. In the past 4 years, we have seen dramatic revenue growth every year. With this new funding, we now aim to significantly accelerate this growth," Paul Lichty, Forge Nano CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.